Comparison of loss of heterozygosity in primary and recurrent ductal carcinoma in situ of the breast

Modern Pathology

Volumn 11, Issue 12, 1998, Pages 1151-1159

  Lininger, Ruth A ^a   Fujii, Hiroaki ^b,c   Man, Yan Gao ^a   Gabrielson, Edward ^b   Tavassoli, Fattaneh A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarkers; Breast; Genetics; Neoplasms; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME 17P; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT CANCER;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; FEMALE; HUMANS; LONGITUDINAL STUDIES; LOSS OF HETEROZYGOSITY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION;

EID: 0032437875     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-8.
2. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
3. Margolin FR, Lagios MD. Mammographic detection of early breast cancer: 10 years' experience in a community hospital. West J Med 1986;144:46-8.
4. Ashikari R, Hajdu SI, Robbins GF. Intraductal carcinoma of the breast (1960-1969). Cancer 1971;28:1182-7.
5. Fowble B, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Patchevsky A, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997;38:949-57.
6. Hiramatsu H, Bornstein BA, Recht A, Schnitt SJ, Baum JK, Connolly JL, et al. Local recurrence after conservative surgery and irradiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am 1995; 1:55-61.
7. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31:1425-7.
8. Sneige N, McNeese MD, Atkinson EN, Ames FC, Kemp B, Sahin A, Ayala AG. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathologic analysis of 49 specimens with emphasis on risk factors and long-term results. Hum Pathol 1995;26:642-9.
9. Vicini FA, Lacerna MD, Horwitz EM, White J, Gustafson GS, Martinez AA. Mammographically detected DCIS treated with breast-conserving therapy: an analysis of clinical, pathologic, and treatment-related factors affecting outcome [abstract]. Int J Radiat Oncol Biol Phys 1996;36(Suppl):214.
10. Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, et al. Mammographically detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996;2:158-65.
11. White J, Levine A, Gustafson G, Wimbish K, Ingold J, Pettinga J, et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:791-7.
12. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
13. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75:1310-9.
14. Van Zee, P, Liberman L, McCormick B, TKN, Petrek J, Bergen P. Long-term follow-up of DCIS treated with breast conservation: effect of age and radiation. Proc Soc Surg Oncol 1996;26:21-4.
15. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J. Duct carcinoma in situ of the breast: an analysis of local control after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991;21:289-92.
16. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-74.
17. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990;65:518-29.
18. Tavassoli FA. Pathology of the breast. Norwalk, CT: Appleton & Lange; 1992. p. 193-228.
19. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2.
20. Fujii H, Marsh C, Cairns P, Sidransky D, Gabrielson E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996;56:1493-7.
21. Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E. Genetic progression, histologic grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 1996;56:5260-5.
22. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, et al. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 1997;57:5469-74.
23. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p, and 17q. Cancer Res 1995;55:3399-405.
24. O'Connell P, Pekkel V, Fuqua SAW, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90:697-703.
25. Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosom Cancer 1996;16:189-95.
26. Anbazhagan R, Fujii H, Gabrielson E. Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol 1998;152:815-9.
27. Yaremko ML, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chromosomes Cancer 1995;13:186-91.
28. Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 1997;150:297-303.
29. Champeme M-H, Bieche I, Lizard S, Lidereau R. 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosomes Cancer 1995;12:128-33.
30. Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, et al. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 1995;55: 2660-4.
31. Tsuda H, Callen D, Fukutomi T, Nakamura Y, Hirohashi S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 1994;54:513-7.
32. Lakhani SR, Collins N, Stratton MR, Sloane JP. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995;48:611-5.
33. Chen T, Sahin A, Aldaz M. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor genes region. Cancer Res 1996;56:5605-9.
34. Driouch K, Dorion-Bonnet F, Briffod M, Champeme M-H, Longy M, Lidereau R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastasis. Genes Chromosomes Cancer 1997;19:185-91.
35. Allred DC, Berardo MD, Prosser J, O'Connell P. Biologic and genetic features of in situ breast cancer. In: Silverstein MJ, editor. Ductal carcinoma of the breast. Baltimore: Williams & Wilkins; 1997. p. 37-49.
36. Radford DM, Fair K, Thompson AM, Ritter JH, Holt M, Steinbrueck T, et al. Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 1993;53:2947-50.
37. Johnson JE, Page DL, Winfield AC, Reynolds VH, Sawyers JL. Recurrent mammary carcinoma after local excision: a segmental problem. Cancer 1995;75:1612-8.
38. Tavassoli FA. Mammary intraepithelial neoplasia: a translational classification system for the intraductal epithelial proliferations. Breast J 1997;3:48-58.
39. Ohuchi N, Furuta A, Mori S. Management of ductal carcinoma in situ with nipple discharge: intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery. Cancer 1994;74:1294-302.
40. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery: computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995;76:32-45.